Healthcare -
Biotechnology - NASDAQ - US
$ 21.93
1.2 %
$ 3.16 B
Market Cap
-7.95
P/E
DNLI - REVENUE
Revenue DNLI - Denali Therapeutics Inc.
331 M
LAST VALUE
160.62%
2 YEAR CAGR
20.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR